Periodontal Tissue Distribution of Cefpodoxime Proxetil and Efficacy in Acute Odontogenic Infections
- 1 June 1993
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 5 (6) , 313-319
- https://doi.org/10.1007/bf03259238
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Trials of Cefpodoxime Proxetil Suspension in PaediatricsDrugs, 1991
- Cefpodoxime Proxetil in the Treatment of Skin and Soft Tissue InfectionsDrugs, 1991
- Review of Clinical Experience in the United States with Cefpodoxime Proxetil in Adults with Uncomplicated Urinary Tract InfectionsDrugs, 1991
- A Review of the Pharmacokinetics of Cefpodoxime ProxetilDrugs, 1991
- Microbiological Evaluation of Cefpodoxime ProxetilDrugs, 1991
- Summary of Clinical Experience with Cefpodoxime Proxetil in Adults in JapanDrugs, 1991
- Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetilAntimicrobial Agents and Chemotherapy, 1990
- The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporinsJournal of Antimicrobial Chemotherapy, 1990
- Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)Antimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1987